5:@0.498743:0.961646:0.507143:0.961646:0.507143:0.945381:0.498743:0.945381:0.008399
百靈佳殷格翰:@0.449093:0.047478:0.549886:0.047478:0.549886:0.035100:0.449093:0.035100:0.016799:0.016799:0.016799:0.016799:0.016799:0.016799
1917 年成立科學部門與海因裡:@0.245918:0.449594:0.531673:0.449594:0.531673:0.435979:0.245918:0.435979:0.009239:0.009239:0.009239:0.009239:0.005616:0.022470:0.022470:0.022470:0.022470:0.022470:0.022470:0.022470:0.022470:0.022470:0.022470:0.018479
希． 威 蘭（Heinrich  Wieland，:@0.245918:0.473422:0.531632:0.473422:0.531632:0.459806:0.245918:0.459806:0.018479:0.018479:0.011982:0.018479:0.011980:0.018479:0.018479:0.009239:0.009239:0.009239:0.009239:0.009239:0.009239:0.009239:0.009239:0.009239:0.003049:0.009239:0.009239:0.009239:0.009239:0.009239:0.009239:0.009239:0.018479
一九二七年諾貝爾化學 ? 得主）合:@0.245918:0.497250:0.531647:0.497250:0.531647:0.483634:0.245918:0.483634:0.019163:0.019163:0.019163:0.019163:0.019163:0.019163:0.019163:0.019163:0.019163:0.018479:0.004790:0.009239:0.004792:0.019163:0.019163:0.019163:0.018479
作，以及一九五○年前後與輝瑞:@0.245918:0.521078:0.531675:0.521078:0.531675:0.507462:0.245918:0.507462:0.018479:0.020733:0.020733:0.020733:0.020733:0.020733:0.020733:0.020733:0.020733:0.020733:0.020733:0.020733:0.020733:0.018479
（Pfizer）、諾佛（Novo）、嘉基:@0.245918:0.544906:0.531632:0.544906:0.531632:0.531290:0.245918:0.531290:0.018479:0.009239:0.009239:0.009239:0.009239:0.009239:0.009239:0.018479:0.020611:0.020613:0.018479:0.018479:0.009239:0.009239:0.009239:0.009239:0.018479:0.020611:0.020611:0.018479
（Geigy）藥廠合作，以期成立國際:@0.245918:0.568734:0.531632:0.568734:0.531632:0.555118:0.245918:0.555118:0.018479:0.009239:0.009239:0.009239:0.009239:0.009239:0.018126:0.018479:0.018479:0.018479:0.018479:0.018124:0.018479:0.018479:0.018479:0.018479:0.018479:0.018479
業務合作關係，只是其中兩個具有:@0.245918:0.592562:0.531656:0.592562:0.531656:0.578946:0.245918:0.578946:0.019135:0.019135:0.019144:0.019135:0.019135:0.018479:0.019135:0.019135:0.019144:0.019135:0.019135:0.019135:0.019135:0.019144:0.018479
歷史意義的重要合作範例。我們不:@0.245918:0.616390:0.531656:0.616390:0.531656:0.602774:0.245918:0.602774:0.019135:0.019135:0.019144:0.019135:0.019135:0.019135:0.019135:0.019144:0.019135:0.019135:0.018479:0.019135:0.019135:0.019144:0.018479
僅僅是要創新藥品疫苗，未來在努:@0.245918:0.640218:0.531656:0.640218:0.531656:0.626602:0.245918:0.626602:0.019135:0.019135:0.019144:0.019135:0.019135:0.019135:0.019135:0.019144:0.019135:0.018479:0.019135:0.019135:0.019135:0.019144:0.018479
力提供顧客顯著且在負擔能力內的:@0.245918:0.664046:0.531638:0.664046:0.531638:0.650430:0.245918:0.650430:0.019089:0.019089:0.019089:0.019089:0.019089:0.019089:0.019089:0.019089:0.019089:0.019089:0.019089:0.019089:0.019089:0.019089:0.018479
治療過程方面，合作關係會持續發:@0.245918:0.687874:0.531656:0.687874:0.531656:0.674258:0.245918:0.674258:0.019135:0.019135:0.019144:0.019135:0.019135:0.018479:0.019135:0.019135:0.019144:0.019135:0.019135:0.019135:0.019135:0.019144:0.018479
揮重要的作用。只有在最具有創新:@0.245918:0.711702:0.531656:0.711702:0.531656:0.698086:0.245918:0.698086:0.019135:0.019135:0.019144:0.019135:0.019135:0.018479:0.019135:0.019135:0.019144:0.019135:0.019135:0.019135:0.019135:0.019144:0.018479
精神的企業共同努力，我們才能夠:@0.245918:0.735530:0.531656:0.735530:0.531656:0.721914:0.245918:0.721914:0.019135:0.019135:0.019144:0.019135:0.019135:0.019135:0.019135:0.019144:0.018479:0.019135:0.019135:0.019135:0.019135:0.019144:0.018479
找到解決方案──同時維持家族企:@0.245918:0.759358:0.531638:0.759358:0.531638:0.745742:0.245918:0.745742:0.019089:0.019089:0.019089:0.019089:0.019089:0.019089:0.019089:0.019089:0.019089:0.019089:0.019089:0.019089:0.019089:0.019089:0.018479
業的獨立性。:@0.245918:0.783186:0.356791:0.783186:0.356791:0.769570:0.245918:0.769570:0.018479:0.018479:0.018479:0.018479:0.018479:0.018479
》攜手努力尋找解決方案《:@0.567619:0.753663:0.849841:0.753663:0.849841:0.736333:0.567619:0.736333:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519
CHRISTIAN BOEHRINGER:@0.567619:0.786594:0.735608:0.786594:0.735608:0.775586:0.567619:0.775586:0.009703:0.009703:0.009703:0.003736:0.008964:0.008211:0.003736:0.009703:0.009703:0.003736:0.009703:0.010456:0.008964:0.009703:0.009703:0.003736:0.009703:0.010456:0.008964:0.009703
─────────:@0.567619:0.796365:0.749047:0.796365:0.749047:0.781511:0.567619:0.781511:0.020159:0.020159:0.020159:0.020159:0.020159:0.020159:0.020159:0.020159:0.020159
股東委員會主席:@0.567619:0.806265:0.685211:0.806265:0.685211:0.793887:0.567619:0.793887:0.016799:0.016799:0.016799:0.016799:0.016799:0.016799:0.016799
百靈佳殷格翰:@0.449606:0.047483:0.550400:0.047483:0.550400:0.035105:0.449606:0.035105:0.016799:0.016799:0.016799:0.016799:0.016799:0.016799